UNSPSC 51422313: Paramethasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VFC6ZX3584, chemically known as pregna-1,4-diene-3,20-dione, 6-fluoro-11,17,21-trihydroxy-16-methyl-, (6alpha,11beta,16alpha)- but generally known as paramethasone, which bears US NIH Compound Identifier 5875. European Medicines Agency schedules Paramethasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09614MIG.

UNSPSC 51422313 Paramethasone, a Commodity code, encompasses pharmaceutical products procured by state and local health agencies—though recent opportunities under this code tag show minimal alignment with the code's specific pharmaceutical focus. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the county's community health building and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesale channels. State and local procurement under this code draws from county health departments and state health agencies seeking pharmaceutical inventory for public health and emergency response programs, though the recent-opportunities sample is limited to two records with divergent scope.

Geographic activity centers on Texas and Florida based on the available records, with no other states represented in the recent opportunities. Seminole County's naloxone procurement (IFB, response due July 26, 2023, though posted June 30, 2026) required vendors to submit unit costs electronically, include all shipping and delivery costs in proposals, maintain workers' compensation and commercial general liability insurance, and complete E-Verify compliance and drug-free workplace certification—with a three-month probationary termination provision and potential FEMA funding triggering federal environmental compliance (Clean Air Act, Federal Water Pollution Control Act). Texas HHS's RFI (posted April 3, 2026, same-day response deadline) was exploratory only, seeking vendor experience with direct contracting to self-insured employer and government health plans using negotiated net pricing without rebates, and information on outcomes-based agreement capability—with no award value, budget range, or formal evaluation criteria specified at the information-gathering stage.